Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 496–510 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2570 MPL Gene Mutation Test This test identifies mutations in the MPL gene, which are associated with certain types of myeloproliferative neoplasms.	Peripheral whole blood (3 mL EDTA lavender-top tube)	2–3 working days (Monday–Saturday reporting)	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MPL gene pathogenic variants", "Variant Allele Frequency (VAF)"] Parameters [] Preparation ["No fasting required", "Collect 3 mL whole blood in EDTA lavender-top tube", "Include Genomics Clinical Information Form (Form 20)"] Indications ["Confirmation of essential thrombocythemia", "Diagnosis of primary myelofibrosis", "Evaluation of Philadelphia-negative MPNs"] Measurement technique Confirm with laboratory Codes LOINC: 55441-9 ICD-10: D47.3, D47.1 Clinical summary This test identifies mutations in the MPL gene, which are associated with certain types of myeloproliferative neoplasms.
TEST-5895 MPS Enzyme Panel (Genetic Test) This genetic test identifies pathogenic variants in genes associated with Mucopolysaccharidoses (MPS), a group of inherited lysosomal storage disorders.	Whole blood (EDTA), dried blood spot (FTA card), or extracted DNA	3–4 weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in MPS-associated genes", "Enzyme deficiencies at the genetic level"] Parameters [] Preparation [] Indications ["Clinical suspicion of MPS based on symptoms", "Family history of MPS", "Confirmation of diagnosis", "Genetic counselling and family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81960-4 ICD-10: E76.0, E76.1, E76.2 Clinical summary This genetic test identifies pathogenic variants in genes associated with Mucopolysaccharidoses (MPS), a group of inherited lysosomal storage disorders.
TEST-2103 MSH2 Gene Lynch Syndrome (HNPCC) Genetic Test This test evaluates the MSH2 gene for inherited mutations associated with Lynch syndrome (HNPCC), a condition increasing the risk of various cancers.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MSH2 gene sequence", "Copy Number Variations (CNV) in MSH2"] Parameters [] Preparation ["No special preparation is required", "Ensure you are well-hydrated for easier venous access"] Indications ["Individuals with a personal or family history suggestive of Lynch syndrome", "Risk stratification for hereditary cancer predisposition"] Measurement technique Confirm with laboratory Codes LOINC: 35095-5 ICD-10: Z15.09, Z80.0 Clinical summary This test evaluates the MSH2 gene for inherited mutations associated with Lynch syndrome (HNPCC), a condition increasing the risk of various cancers.
TEST-2001 MSH2 Gene Mismatch Repair Cancer Syndrome Genetic Test This genetic test evaluates the MSH2 gene for mutations associated with Lynch syndrome, a hereditary cancer predisposition.	Peripheral whole blood or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MSH2 gene mutations (SNVs, indels, CNVs)", "Germline genetic variations"] Parameters [{"name": "MSH2 Gene Analysis", "reference_range": "No pathogenic variants detected"}] Preparation ["Do not discontinue prescribed medications without consulting your doctor.", "A pre-test genetic counselling session is mandatory."] Indications ["Individuals with a personal or family history of Lynch-associated cancers", "Cascade testing for family members of individuals with known MSH2 mutations", "Diagnosis of Lynch syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 45068-8 ICD-10: Z15.09 Clinical summary This genetic test evaluates the MSH2 gene for mutations associated with Lynch syndrome, a hereditary cancer predisposition.
TEST-4742 MT-ND6 Gene Genetic Test for Leigh Syndrome (Mitochondrial Complex I Deficiency) This test detects pathogenic mutations in the MT-ND6 gene, confirming Leigh syndrome caused by mitochondrial complex I deficiency.	Peripheral whole blood or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MT-ND6 gene", "Coding and deep intronic variants"] Parameters [] Preparation ["No fasting required", "No medication cessation required", "Pre-test genetic counselling is mandatory"] Indications ["Infants and children with progressive encephalopathy, hypotonia, and developmental regression", "Family members with a known history of Leigh syndrome for carrier detection"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G31.81 Clinical summary This test detects pathogenic mutations in the MT-ND6 gene, confirming Leigh syndrome caused by mitochondrial complex I deficiency.
TEST-4375 MT-TW Gene Mitochondrial Encephalopathy Genetic Test This genetic test identifies pathogenic variants in the MT-TW gene associated with mitochondrial encephalopathy.	Whole blood, extracted DNA, or dried blood spot (FTA® card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MT-TW gene sequence", "Pathogenic variants"] Parameters [] Preparation ["A genetic counselling session is mandatory to draw a detailed pedigree of affected family members."] Indications ["Suspected mitochondrial encephalopathy", "Family history suggestive of maternal inheritance"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G31.81, G31.89 Clinical summary This genetic test identifies pathogenic variants in the MT-TW gene associated with mitochondrial encephalopathy.
TEST-6094 MT‑RNR2 Gene Chloramphenicol Resistance Genetic Test This test evaluates the MT‑RNR2 gene for variants associated with altered cellular response to chloramphenicol.	Peripheral Whole Blood (EDTA tube)	3-4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MT‑RNR2 gene variants", "Chloramphenicol resistance/toxicity susceptibility"] Parameters [] Preparation [] Indications ["Patients prescribed or considering chloramphenicol therapy", "Assessment of chloramphenicol toxicity risk"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Z15.89, Z13.71, Y40.2 Clinical summary This test evaluates the MT‑RNR2 gene for variants associated with altered cellular response to chloramphenicol.
TEST-1373 MTHFR Gene Mutation Analysis (C677T & A1298C) Test This test evaluates the presence of the C677T and A1298C variants in the MTHFR gene.	Peripheral Whole Blood	3–4 Days	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MTHFR C677T variant", "MTHFR A1298C variant", "Folate metabolism pathway"] Parameters [{"name": "MTHFR C677T", "reference_range": "Wild-type (CC), Heterozygous (CT), Homozygous (TT)"}, {"name": "MTHFR A1298C", "reference_range": "Wild-type (AA), Heterozygous (AC), Homozygous (CC)"}] Preparation ["No fasting required", "No medication or supplement stoppage needed"] Indications ["Assessment of risk for cardiovascular disease", "Evaluation of risk for venous thromboembolism", "Investigation of recurrent pregnancy loss", "Guidance for folate supplementation"] Measurement technique Confirm with laboratory Codes LOINC: 48768-8 ICD-10: Z13.89 Clinical summary This test evaluates the presence of the C677T and A1298C variants in the MTHFR gene.
TEST-2584 MTHFR Gene Mutation Qualitative PCR Test This test identifies the presence or absence of the C677T and A1298C mutations in the MTHFR gene.	Whole Blood (Peripheral Venipuncture)	4 Days	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MTHFR C677T variant", "MTHFR A1298C variant"] Parameters [] Preparation ["Complete Genomics Form 20 accurately", "Provide full medical history, current medications, and family history of clotting disorders"] Indications ["Thrombophilia screening", "Risk stratification for venous thromboembolism", "Evaluation of recurrent pregnancy loss", "Guidance for folate supplementation"] Measurement technique Confirm with laboratory Codes LOINC: 21693-6 ICD-10: Z13.6, Z13.29, Z15.89 Clinical summary This test identifies the presence or absence of the C677T and A1298C mutations in the MTHFR gene.
TEST-1323 Muscular Dystrophy Gene Panel (NGS) Test This test identifies genetic mutations associated with various forms of muscular dystrophy.	Standard Venous Whole Blood (EDTA) or DNA FTA Card	4 to 5 weeks	2,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in muscular dystrophy-associated genes", "Carrier status for specific muscular dystrophy genes"] Parameters [] Preparation ["No special dietary preparation or fasting required", "Bring valid Emirates ID, health insurance card, and physician referral/prescription", "Inform phlebotomist if on anticoagulant therapy"] Indications ["Diagnosis of suspected muscular dystrophy", "Carrier screening for family members", "Prognostic assessment", "Eligibility assessment for gene therapies"] Measurement technique Confirm with laboratory Codes LOINC: 98134-7 ICD-10: G71.0 Clinical summary This test identifies genetic mutations associated with various forms of muscular dystrophy.
TEST-5196 MUSK Gene Myasthenic Syndrome Associated with Acetylcholine Receptor Deficiency Genetic Test This genetic test identifies pathogenic variants in the MUSK gene associated with congenital myasthenic syndrome.	Whole blood (EDTA tube), dried blood spot (FTA card), or extracted DNA (≥ 1 µg).	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MUSK gene", "Copy-number variations (CNV) in the MUSK gene"] Parameters [] Preparation ["Provide detailed clinical history, including neuromuscular symptoms and family pedigree.", "Mandatory pre-genetic counselling session required.", "No fasting or medication adjustment required."] Indications ["Confirm CMS diagnosis", "Guide immunomodulatory therapy", "Monitor neuromuscular junction disorders", "Investigate CMS pathophysiology", "Predictive or pre-symptomatic testing in family members"] Measurement technique Confirm with laboratory Codes LOINC: 10165-4 ICD-10: G70.2, Z14.01, Z82.3 Clinical summary This genetic test identifies pathogenic variants in the MUSK gene associated with congenital myasthenic syndrome.
TEST-1393 Mycobacterium tuberculosis First- & Second-Line Drug Resistance Profile (Line Probe Assay) Test This diagnostic test evaluates genetic mutations in Mycobacterium tuberculosis that confer resistance to first- and second-line anti-TB medications.	Sputum, Bronchoalveolar Lavage (BAL), or Respiratory Specimen	5 business days (Sample by 11 am Saturday → Report Friday)	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetic mutations in rpoB, katG, inhA, gyrA, rrs genes", "Resistance to Isoniazid, Rifampicin, Fluoroquinolones, Injectable agents"] Parameters [{"name": "Isoniazid Resistance", "reference_range": "Negative (Susceptible)"}, {"name": "Rifampicin Resistance", "reference_range": "Negative (Susceptible)"}, {"name": "Fluoroquinolone Resistance", "reference_range": "Negative (Susceptible)"}, {"name": "Injectable Agent Resistance", "reference_range": "Negative (Susceptible)"}] Preparation ["No specific fasting required.", "Collect sample before starting anti-TB treatment if possible."] Indications ["Suspected pulmonary or extrapulmonary tuberculosis", "Patients with prior TB treatment failure", "Patients with known exposure to drug-resistant TB", "Patients requiring rapid confirmation of drug susceptibility"] Measurement technique Confirm with laboratory Codes LOINC: 76968-1 ICD-10: A15.0, A15.4 Clinical summary This diagnostic test evaluates genetic mutations in Mycobacterium tuberculosis that confer resistance to first- and second-line anti-TB medications.
TEST-1317 MYD88 Gene Mutation Analysis Test This test identifies the presence or absence of the MYD88 L265P somatic mutation in peripheral blood.	Peripheral whole blood (EDTA tube)	5–7 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MYD88 L265P mutation", "Somatic gene mutation"] Parameters [{"name": "MYD88 L265P Mutation", "reference_range": "Negative / Positive"}] Preparation ["No fasting required.", "No medication adjustments required unless directed by your doctor.", "A prescription from a DHA-licensed physician is mandatory."] Indications ["Diagnosis of Waldenström macroglobulinemia", "Diagnosis of activated B-cell lymphomas", "Prognosis stratification in B-cell neoplasms", "Guidance for targeted therapy (e.g., BTK inhibitors)"] Measurement technique Confirm with laboratory Codes LOINC: 83011-4 ICD-10: C88.0, C83.30, D84.8 Clinical summary This test identifies the presence or absence of the MYD88 L265P somatic mutation in peripheral blood.
TEST-2171 Myeloid Tumor Panel Genetic Test This test evaluates 37 genes associated with myeloid malignancies using Next-Generation Sequencing (NGS) to identify mutations relevant for diagnosis, prognosis, and treatment sele...	Peripheral Whole Blood (EDTA or FTA Card) or Bone Marrow Aspirate	21–28 Calendar Days (3–4 Weeks)	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Somatic and germline mutations", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [{"name": "Genes Analyzed", "reference_range": "37 Genes (ASXL1, TP53, FLT3, IDH1, IDH2, RUNX1, TET2, DNMT3A, SF3B1, SRSF2, U2AF1, CEBPA, NPM1, KIT, KRAS, NRAS, JAK2, CALR, MPL, EZH2, STAG2, BCOR, BCORL1, ZRSR2, RAD21, SMC1A, SMC3, PHF6, NF1, PTPN11, CBL, SETBP1, ETNK1, GATA2, WT1, IKZF1, MYD88)"}] Preparation ["No specific fasting required", "Inform lab if patient received blood transfusion within 48 hours"] Indications ["Diagnosis of AML, MDS, or MPN", "Prognosis assessment in myeloid malignancies", "Guidance for targeted therapy selection", "Minimal residual disease (MRD) monitoring"] Measurement technique Confirm with laboratory Codes LOINC: 92833-1 ICD-10: C92.0 Clinical summary This test evaluates 37 genes associated with myeloid malignancies using Next-Generation Sequencing (NGS) to identify mutations relevant for diagnosis, prognosis, and treatment selection.
TEST-1321 Myeloproliferative Leukemia Mutation Screening (MPL Test This test identifies specific mutations (S505N, W515L) in the MPL gene, which are associated with certain types of myeloproliferative neoplasms.	Bone Marrow Aspirate or Peripheral Blood	5–7 calendar days	900.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MPL S505N mutation", "MPL W515L mutation"] Parameters [] Preparation [] Indications ["Suspected essential thrombocythemia", "Suspected primary myelofibrosis", "Exclusion of JAK2 V617F mutation"] Measurement technique Confirm with laboratory Codes LOINC: 92743-3 ICD-10: D47.3, D47.4, D47.9 Clinical summary This test identifies specific mutations (S505N, W515L) in the MPL gene, which are associated with certain types of myeloproliferative neoplasms.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories